Meg Wood

Meg Wood is currently the SVP of Ventures and Business Development at New York Blood Center. Meg also holds the position of Managing Director at NYBC Ventures, which aims to advance innovation in blood-related fields and cellular therapies. In addition, Meg serves as a Board Member or Observer at several companies including Aronora, Inc., VERALOX Therapeutics, Thymmune Therapeutics, Catena Biosciences, and Rarebase. With a background in public health and management, Meg has previously worked at CureDuchenne and MPM Capital, showcasing their expertise in business development and marketing.